Literature DB >> 7821418

A catalytic subunit of calpain possesses full proteolytic activity.

T Yoshizawa1, H Sorimachi, S Tomioka, S Ishiura, K Suzuki.   

Abstract

Previous studies on the refolding of calpain, a heterodimer comprising a catalytic 80 kDa subunit and a regulatory 30 kDa subunit, indicate that both subunits are required for the expression of full protease activity. We reexamined the conditions for refolding of calpain and found that under optimized conditions the renatured 80 kDa subunit has full enzyme activity even in the absence of the 30 kDa subunit. The 30 kDa subunit stabilizes the 80 kDa subunit rather than enhancing its activity. The theory that calpain functions as a dimer requires reexamination.

Mesh:

Substances:

Year:  1995        PMID: 7821418     DOI: 10.1016/0014-5793(94)01401-l

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division.

Authors:  J S Arthur; J S Elce; C Hegadorn; K Williams; P A Greer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium.

Authors:  S Strobl; C Fernandez-Catalan; M Braun; R Huber; H Masumoto; K Nakagawa; A Irie; H Sorimachi; G Bourenkow; H Bartunik; K Suzuki; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

4.  Purification of native p94, a muscle-specific calpain, and characterization of its autolysis.

Authors:  K Kinbara; S Ishiura; S Tomioka; H Sorimachi; S Y Jeong; S Amano; H Kawasaki; B Kolmerer; S Kimura; S Labeit; K Suzuki
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

5.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

6.  The effects of truncations of the small subunit on m-calpain activity and heterodimer formation.

Authors:  J S Elce; P L Davies; C Hegadorn; D H Maurice; J S Arthur
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

7.  Calcium-binding properties of human erythrocyte calpain.

Authors:  M Michetti; F Salamino; R Minafra; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

8.  Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite.

Authors:  Yimin Wu; Xiangyun Wang; Xia Liu; Yufeng Wang
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

Review 9.  Calpain-14 and its association with eosinophilic esophagitis.

Authors:  Vladislav A Litosh; Mark Rochman; Jeffrey K Rymer; Aleksey Porollo; Leah C Kottyan; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-01-25       Impact factor: 10.793

10.  Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.

Authors:  Steffen Sandmann; Freerk Prenzel; Lee Shaw; Roland Schauer; Thomas Unger
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.